| pubmed-article:15629368 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15629368 | lifeskim:mentions | umls-concept:C0155626 | lld:lifeskim |
| pubmed-article:15629368 | lifeskim:mentions | umls-concept:C0023401 | lld:lifeskim |
| pubmed-article:15629368 | lifeskim:mentions | umls-concept:C0042285 | lld:lifeskim |
| pubmed-article:15629368 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:15629368 | lifeskim:mentions | umls-concept:C0015528 | lld:lifeskim |
| pubmed-article:15629368 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
| pubmed-article:15629368 | lifeskim:mentions | umls-concept:C0040044 | lld:lifeskim |
| pubmed-article:15629368 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15629368 | pubmed:dateCreated | 2005-1-4 | lld:pubmed |
| pubmed-article:15629368 | pubmed:abstractText | The aim of this study was to evaluate the pharmacogenetic role of the factor XIII (FXIII) valine 34 leucine (Val34Leu) polymorphism in the fibrinolytic therapy of acute myocardial infarction (MI). | lld:pubmed |
| pubmed-article:15629368 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15629368 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15629368 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15629368 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15629368 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15629368 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15629368 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15629368 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:15629368 | pubmed:issn | 0735-1097 | lld:pubmed |
| pubmed-article:15629368 | pubmed:author | pubmed-author:XXX | lld:pubmed |
| pubmed-article:15629368 | pubmed:author | pubmed-author:LipGregory... | lld:pubmed |
| pubmed-article:15629368 | pubmed:author | pubmed-author:MarínFrancisc... | lld:pubmed |
| pubmed-article:15629368 | pubmed:author | pubmed-author:RoldánVanessa... | lld:pubmed |
| pubmed-article:15629368 | pubmed:author | pubmed-author:SogorbFrancis... | lld:pubmed |
| pubmed-article:15629368 | pubmed:author | pubmed-author:LeeKaeng WKW | lld:pubmed |
| pubmed-article:15629368 | pubmed:author | pubmed-author:CorralJavierJ | lld:pubmed |
| pubmed-article:15629368 | pubmed:author | pubmed-author:González-Cone... | lld:pubmed |
| pubmed-article:15629368 | pubmed:author | pubmed-author:LópezFrancisc... | lld:pubmed |
| pubmed-article:15629368 | pubmed:author | pubmed-author:CaturlaJuanJ | lld:pubmed |
| pubmed-article:15629368 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15629368 | pubmed:day | 4 | lld:pubmed |
| pubmed-article:15629368 | pubmed:volume | 45 | lld:pubmed |
| pubmed-article:15629368 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15629368 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15629368 | pubmed:pagination | 25-9 | lld:pubmed |
| pubmed-article:15629368 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15629368 | pubmed:meshHeading | pubmed-meshheading:15629368... | lld:pubmed |
| pubmed-article:15629368 | pubmed:meshHeading | pubmed-meshheading:15629368... | lld:pubmed |
| pubmed-article:15629368 | pubmed:meshHeading | pubmed-meshheading:15629368... | lld:pubmed |
| pubmed-article:15629368 | pubmed:meshHeading | pubmed-meshheading:15629368... | lld:pubmed |
| pubmed-article:15629368 | pubmed:meshHeading | pubmed-meshheading:15629368... | lld:pubmed |
| pubmed-article:15629368 | pubmed:meshHeading | pubmed-meshheading:15629368... | lld:pubmed |
| pubmed-article:15629368 | pubmed:meshHeading | pubmed-meshheading:15629368... | lld:pubmed |
| pubmed-article:15629368 | pubmed:meshHeading | pubmed-meshheading:15629368... | lld:pubmed |
| pubmed-article:15629368 | pubmed:meshHeading | pubmed-meshheading:15629368... | lld:pubmed |
| pubmed-article:15629368 | pubmed:meshHeading | pubmed-meshheading:15629368... | lld:pubmed |
| pubmed-article:15629368 | pubmed:meshHeading | pubmed-meshheading:15629368... | lld:pubmed |
| pubmed-article:15629368 | pubmed:meshHeading | pubmed-meshheading:15629368... | lld:pubmed |
| pubmed-article:15629368 | pubmed:meshHeading | pubmed-meshheading:15629368... | lld:pubmed |
| pubmed-article:15629368 | pubmed:meshHeading | pubmed-meshheading:15629368... | lld:pubmed |
| pubmed-article:15629368 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15629368 | pubmed:articleTitle | A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction. | lld:pubmed |
| pubmed-article:15629368 | pubmed:affiliation | Cardiology Department, Hospital General Universitario, Alicante, Spain. | lld:pubmed |
| pubmed-article:15629368 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15629368 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15629368 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| entrez-gene:2162 | entrezgene:pubmed | pubmed-article:15629368 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:15629368 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15629368 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15629368 | lld:pubmed |
